Huntington Park Medical Practice and Doctor to Pay More Than $6.7 Million to Settle Allegations of Billing Medicare for Unnecessary Procedures

Why It Matters

The enforcement action protects taxpayer dollars and reinforces compliance standards for providers billing federal health programs. It also signals that excessive or undocumented procedures will trigger significant civil penalties.

Key Takeaways

• Dr. Serrano to pay $6.73 million for Medicare fraud.
• Settlement includes $6.51 million federal and $229 k California payments.
• Whistleblower Lincoln Analytics receives $976 k under qui tam provision.
• Unnecessary dialysis and peripheral artery procedures performed on 20 Medicare patients.
• Case highlights DOJ’s aggressive enforcement of the False Claims Act.

Pulse Analysis

The U.S. Department of Justice continues to prioritize the recovery of fraudulent Medicare payments, leveraging the False Claims Act as its primary weapon. In recent years, the agency has secured billions of dollars by targeting providers who submit claims for services that are either medically unnecessary or improperly documented. This aggressive posture serves a dual purpose: protecting taxpayer funds and preserving the integrity of federal health programs such as Medicare and Medicaid. The latest settlement involving a Los Angeles‑area vascular practice underscores how even specialty clinics are not immune to scrutiny.

The case centers on Dr. Feliciano Serrano, who allegedly performed a series of unwarranted dialysis‑access and peripheral artery interventions on at least 20 Medicare beneficiaries between 2016 and 2024. Patients were subjected to repeated angioplasties, stent placements, and atherectomies despite minimal or absent clinical indications, inflating reimbursement claims by millions of dollars. A whistleblower, Lincoln Analytics, triggered the qui tam lawsuit and will receive roughly $976 k of the recovered funds. The settlement obliges Dr. Serrano to pay more than $6.73 million, split between the federal government and California.

Healthcare providers should view this outcome as a warning that excessive or undocumented procedures will attract federal enforcement. Robust compliance programs, thorough documentation of symptom severity, and adherence to evidence‑based treatment guidelines are now essential safeguards. For billing departments, regular audits and clear escalation paths for questionable orders can mitigate risk. As the Justice Department’s Task Force to Eliminate Fraud expands its reach, physicians and clinics that prioritize patient‑centered care over revenue generation will be better positioned to avoid costly settlements and reputational damage.